by Andreu Prados
With nearly 240 participants from 27 countries, the 14th edition of GMFH World Summit covered basic, translational and clinical science supporting the integration of microbiome-targeted interventions into preventive and therapeutic strategies for gastrointestinal disorders, cardiometabolic diseases, and cancer.
by Andreu Prados
While “gut health” is becoming a popular term, mainly in media and marketing claims but also in the clinical context, researchers have not yet nailed down a definition. Now, a global group of 13 scientists and clinicians updates a consensus definition of gut health and implications from bench to bedside.
by Nathalie Rolhion, Harry Sokol
Antibiotic treatments can profoundly disrupt gut microbiome structure and function. This article reviews new findings showing how Saccharomyces boulardii CNCM I-745 helps preserve microbial activity and metabolic resilience during antibiotic stress, with insights from advanced in vitro models and immune assays.
by Karen Madsen
Previous clinical studies have shown a promising role of fecal microbiota transplantation to induce remission in ulcerative colitis and maintain steroid-induced Crohn’s disease remission. A new double-blind, placebo-controlled trial found fecal microbiota transplantation is not effective at inducing clinical or endoscopic remission in adults with Crohn’s disease.
The 6th biennial meeting of the European Society of Neurogastroenterology and Motility, held at Queen Mary University of London, UK, from 4-6 September 2025, covered basic, translational, and clinical research in neurogastroenterology, including dietary therapies and ‘biotics’ for the management of gastrointestinal disorders. Find out more about the main takeaways from the conference.
by Konstantina Zafeiropoulou
Crohn’s disease is an immune-mediated disease without a cure. While current guideline-based therapies are immune-directed therapies (small molecules and biologics), recent advances in understanding how the gut microbiome changes precede and drive disease offer potential for developing personalized therapeutics.
by Premysl Bercik
While the gut microbiome differs between patients with IBS and healthy controls, the precise mechanisms underlying the initial phase of microbial-host interactions are not fully understood. New findings in mice identify a critical role of intestinal dendritic cells’ activation and migration in impacting brain neuroplasticity.
Emerging research suggests a complex interaction between the gut microbiome and endometriosis. Recent studies have begun to explore the impact of dietary interventions on endometriosis.
by Andreu Prados
The 13th Gut Microbiota for Health World Summit took place 15-16 March 2025 in Washington, D.C., and it focused on advances in microbiome research to diagnose, prevent, and manage gastrointestinal and extra-intestinal conditions. Find out more about the most valuable takeaways from the event.
by Andreu Prados
As antibiotic-resistant infections continue to rise worldwide, phage therapy emerges as a promising alternative to antibiotics to tackle this public health threat.
